Washington: New research showcases the effectiveness of bowel cancer screening in reducing approximately 45 per cent deaths.
Bowel or colorectal cancer kills almost 6000 people in Australia each year and 700,000 worldwide but this number would be much higher without pre-diagnostic colonoscopies, says a study published in the journal of ‘BMC Cancer’.
Researchers from UniSA’s Cancer Epidemiology and Population Health found that having one pre-diagnostic colonoscopy was associated with a 17 per cent reduction in cancer deaths — a 27 per cent reduction with two pre-diagnostic colonoscopy procedures and 45 per cent for three or more.
Of the 12,906 records analysed, 37 per cent of the patients had pre-diagnostic colonoscopies and were more likely to live longer than those who were diagnosed after experiencing cancer symptoms.
Dr Ming Li, one of the study leaders, said that in South Australia, where the study was undertaken, those patients who had pre-diagnostic colonoscopies showed a “significant increase” in survival.
“The risk of colorectal cancer death reduces step-wise with increasing numbers of colonoscopy examinations before symptoms appear, cutting the mortality rate from 17 per cent to 45 per cent,” she said.
“Our findings show the value of the National Bowel Screening Program which is now being rolled out to everyone in Australia over the age of 50 on a two-yearly basis. It involves doing a simple, non-invasive fecal occult blood test (FOBT) which, if positive, is followed up with a colonoscopy,” added Dr Li.
Bowel cancer causes the second-highest number of cancer deaths in Australia after lung cancer and is the third most common cancer worldwide, but 90 per cent can be cured if detected early, according to the Cancer Council.
Currently, just 39 per cent of the eligible population in Australia undertakes an FOBT if invited, which is predicted to prevent 92,000 cancer cases in the next 20 years.
If the participation rate were to increase to 60 per cent, an additional 24,300 bowel cancer deaths would be prevented, the Cancer Council estimates.